Alternatives to Respiro Diagnostics

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Automated wet lab for AI-driven protein design, enabling rapid synthesis, expression, and testing of thousands of protein designs.

Earendil Labs is an AI biotechnology company focused on leveraging artificial intelligence for drug discovery and development of next-generation biologics.

A nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.

AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.

AI-native biotech company designing next-generation CAR T therapies for solid tumors.

Revolutionizing genomic analysis with innovative sequencing technology.

Developing a new generation of molecular diagnostics for at-home use, combining laboratory accuracy with rapid test simplicity.

Advancing next-generation mRNA medicines.

AI-enabled technology for cell biology research and biopharma development.

Space BioTech startup developing an autonomous, high-throughput screening platform for drug discovery in microgravity.

Advancing biopsy specimen stewardship and expanding access to precision oncology.

Engineering-driven DNA design platform to overcome biological barriers in genetic medicines.

Biotechnology company defining membrane protein spatial relationships to create novel therapeutics for cancer and autoimmune diseases.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Developing an automated platform for liquid biopsy sample preparation.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).